Guidant/St. Jude Infringement Suit Addresses Ventricular/Atrial Patent Claims
This article was originally published in The Gray Sheet
Executive Summary
Guidant will attempt to prove the validity of its patents '472 and '191 as applying to ventricular as well as atrial devices in an infringement suit against St. Jude Medical scheduled for a June 2001 court date.
You may also be interested in...
Guidant v. St. Jude
St. Jude will seek to have a $140 mil. implantable defibrillator patent infringement damage award to Guidant reduced or set aside, the firm says July 3. Filed in November 1996 in Indianapolis federal court, the complaint focused on four Guidant ICD patents (1"The Gray Sheet" Dec. 11, 2000, p. 11). The jury found that St. Jude infringed Guidant's '472 patent, which expired March 4, but that it did not infringe the firm's '288 patent. Both were ruled to be valid. The court previously dismissed claims on a third patent ('191), although Guidant has appealed that decision. Guidant dropped claims involving a fourth patent, which expired in 1998 ('678). The jury's finding will have no impact on current or future ICD offerings, St. Jude maintains. Post-trial motions must be filed within 10 weeks
Guidant v. St. Jude
St. Jude will seek to have a $140 mil. implantable defibrillator patent infringement damage award to Guidant reduced or set aside, the firm says July 3. Filed in November 1996 in Indianapolis federal court, the complaint focused on four Guidant ICD patents (1"The Gray Sheet" Dec. 11, 2000, p. 11). The jury found that St. Jude infringed Guidant's '472 patent, which expired March 4, but that it did not infringe the firm's '288 patent. Both were ruled to be valid. The court previously dismissed claims on a third patent ('191), although Guidant has appealed that decision. Guidant dropped claims involving a fourth patent, which expired in 1998 ('678). The jury's finding will have no impact on current or future ICD offerings, St. Jude maintains. Post-trial motions must be filed within 10 weeks
St. Jude Dual-Chamber ICD Follow-Ons To Photon On Track, Starks Says
St. Jude Medical expects at least a two-point market share gain in 2001 by entering the more rapidly growing dual-chamber segment of the U.S. implantable cardioverter defibrillator market, in the wake of FDA's Oct. 30 approval of the Photon dual-chamber device.